Baveno VII algorithm outperformed other models in ruling out high-risk varices in individuals with HBV-related cirrhosis
Authors: Xiaofeng Zhang, Jiankang Song, Yuanjian Zhang, Biao Wen, Lin Dai, Ranran Xi, Qiaoping Wu, Yuan Li, Xiaoqin Luo, Xiaoqin Lan, Qinjun He, Wenfan Luo, Qintao Lai, Yali Ji, Ling Zhou, Tingting Qi, Miaoxia Liu, Fuyuan Zhou, Weiqun Wen, Hui Li, Zhihua Liu, Yongpeng Chen, Youfu Zhu, Junying Li, Jing Huang, Xiao Cheng, Minghan Tu, Jinlin Hou, Haiyu Wang, Jinjun Chen
Journal: Journal of Hepatology (2022)

Highlights•We validated the excellent performance of the Baveno VII algorithm for ruling out HRV in those with HBV-related cirrhosis.•Compared with Baveno VI, LSPS, PSR and RESIST, Baveno VII performed best in avoiding unnecessary EGDs.•When applying the Baveno VII algorithm in HBV-related cirrhosis, SSM@100 Hz probe performed better than SSM@50 Hz.AbstractBackground & AimsThe Baveno VII consensus recommends that spleen stiffness measurement (SSM) ≤40 kPa is safe for ruling out high-risk varices (HRVs) and avoiding endoscopic screening in patients who do not meet the Baveno VI criteria. This study aimed to validate the performance of the Baveno VII algorithm in individuals with HBV-related cirrhosis.MethodsConsecutive individuals with HBV-related cirrhosis who underwent liver stiffness measurement (LSM) and SSM – using a 50 Hz shear wave frequency, spleen diameter measurement, and esophagogastroduodenoscopy (EGD) were prospectively enrolled from June 2020. A 100 Hz probe has been adopted for additional SSM assessment since July 2021.ResultsFrom June 2020 to January 2022, 996 patients were screened and 504 were enrolled for analysis. Among the 504 patients in whom SSM was assessed using a 50 Hz probe, the Baveno VII algorithm avoided more EGDs (56.7% vs. 39.1%, p <0.001) than Baveno VI criteria, with a comparable missed HRV rate (3.8% vs. 2.5%). Missed HRV rates were >5% for all other measures: 11.3% for LSM-longitudinal spleen diameter to platelet ratio score, 20.0% for platelet count/longitudinal spleen diameter ratio, and 8.8% for Rete Sicilia Selezione Terapia-hepatitis. SSM@100 Hz was assessed in 232 patients, and the Baveno VII algorithm with SSM@100 Hz spared more EGDs (75.4% vs. 59.5%, p <0.001) than that with SSM@50 Hz, both with a missed HRV rate of 3.0% (1/33).ConclusionsWe validated the Baveno VII algorithm, demonstrating the excellent performance of SSM@50 Hz and SSM@100 Hz in ruling out HRV in individuals with HBV-related cirrhosis. Furthermore, the Baveno VII algorithm with SSM@100 Hz could safely rule out more EGDs than that with SSM@50 Hz.Clinical trial numberNCT04890730.Impact and implicationsThe Baveno VII guideline proposed that for patients who do not meet the Baveno VI criteria, SSM ≤40 kPa could avoid further unnecessary endoscopic screening. The current study validated the Baveno VII algorithm using 50 Hz and 100 Hz probes, which both exhibited excellent performance in ruling out HRVs in individuals with HBV-related cirrhosis. Compared with the Baveno VII algorithm with SSM@50 Hz, SSM@100 Hz had a better capability to safely rule out unnecessary EGDs. Baveno VII algorithm will be a practical tool to triage individuals with cirrhosis in future clinical practice.Graphical abstract